Gustot T - Search Results

1

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).

Weiss E, de la Peña-Ramirez C, Aguilar F, Lozano JJ, Sánchez-Garrido C, Sierra P, Martin PI, Diaz JM, Fenaille F, Castelli FA, Gustot T, Laleman W, Albillos A, Alessandria C, Domenicali M, Caraceni P, Piano S, Saliba F, Zeuzem S, Gerbes AL, Wendon JA, Jansen C, Gu W, Papp M, Mookerjee R, Gambino CG, Jiménez C, Giovo I, Zaccherini G, Merli M, Putignano A, Uschner FE, Berg T, Bruns T, Trautwein C, Zipprich A, Bañares R, Presa J, Genesca J, Vargas V, Fernández J, Bernardi M, Angeli P, Jalan R, Claria J, Junot C, Moreau R, Trebicka J, Arroyo V. Weiss E, et al. Among authors: gustot t. Gut. 2023 Aug;72(8):1581-1591. doi: 10.1136/gutjnl-2022-328708. Epub 2023 Feb 14. Gut. 2023. PMID: 36788015 Free PMC article.

2

The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.

Pradat P, Trepo E, Potthoff A, Bakshi R, Young B, Trepo C, Lagier R, Moreno C, Lemmers A, Gustot T, Degre D, Adler M, Wedemeyer H. Pradat P, et al. Among authors: gustot t. Hepatology. 2010 Jan;51(1):356-7. doi: 10.1002/hep.23223. Hepatology. 2010. PMID: 19824080 No abstract available.

3

Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response.

Gustot T. Gustot T. Curr Opin Crit Care. 2011 Apr;17(2):153-9. doi: 10.1097/MCC.0b013e328344b446. Curr Opin Crit Care. 2011. PMID: 21346564 Review.

4

High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.

Voisset C, de Beeck AO, Horellou P, Dreux M, Gustot T, Duverlie G, Cosset FL, Vu-Dac N, Dubuisson J. Voisset C, et al. Among authors: gustot t. J Gen Virol. 2006 Sep;87(Pt 9):2577-2581. doi: 10.1099/vir.0.81932-0. J Gen Virol. 2006. PMID: 16894196

5

PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis.

Trepo E, Guyot E, Ganne-Carrie N, Degre D, Gustot T, Franchimont D, Sutton A, Nahon P, Moreno C. Trepo E, et al. Among authors: gustot t. Hepatology. 2012 Apr;55(4):1307-8. doi: 10.1002/hep.25518. Hepatology. 2012. PMID: 22162034 No abstract available.

6

[Management of alcoholic hepatitis].

Gustot T, Moreno C. Gustot T, et al. Rev Med Brux. 2012 Sep;33(4):212-4. Rev Med Brux. 2012. PMID: 23091923 Review. French.

7

Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.

Fiore M, Gentile I, Maraolo AE, Leone S, Simeon V, Chiodini P, Pace MC, Gustot T, Taccone FS. Fiore M, et al. Among authors: gustot t. Eur J Gastroenterol Hepatol. 2018 Mar;30(3):329-336. doi: 10.1097/MEG.0000000000001057. Eur J Gastroenterol Hepatol. 2018. PMID: 29303883 Review.

8

Severe sepsis in cirrhosis.

Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Gustot T, et al. Hepatology. 2009 Dec;50(6):2022-33. doi: 10.1002/hep.23264. Hepatology. 2009. PMID: 19885876 Review.

9

Management of bacterial infections in cirrhosis.

Fernández J, Gustot T. Fernández J, et al. Among authors: gustot t. J Hepatol. 2012;56 Suppl 1:S1-12. doi: 10.1016/S0168-8278(12)60002-6. J Hepatol. 2012. PMID: 22300459 Review.

10

Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites.

Sersté T, Gustot T, Rautou PE, Francoz C, Njimi H, Durand F, Valla D, Lebrec D, Moreau R. Sersté T, et al. Among authors: gustot t. J Hepatol. 2012 Aug;57(2):274-80. doi: 10.1016/j.jhep.2012.03.018. Epub 2012 Apr 17. J Hepatol. 2012. PMID: 22521353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page